Francis Patrick Ostronic, Director at Cyclo Therapeutics, Inc. (CYTH), bought 30,000 shares at $4.70 ($140K) on 2020-12-17, disclosed to the SEC on 2020-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.55 | 5,000 | $23K | 16.3% |
| 2 | $4.60 | 5,000 | $23K | 16.5% |
| 3 | $4.69 | 200 | $938 | 0.7% |
| 4 | $4.70 | 19,800 | $93K | 66.6% |
| Total | $4.66 avg | 30,000 | $140K | 100% |
| Filing → |
| CYTH | BUY | 2022-05-23 | $10K | — | Filing → |
| CYTH | BUY | 2022-01-24 | $8K | — | Filing → |
| CYTH | BUY | 2022-01-19 | $5K | — | Filing → |